Generalizability studies of the Global Assessment of Functioning–Split version

Pedersen, Geir; Hagtvet, Knut A.; Karterud, Sigmund

doi:10.1016/j.comppsych.2006.03.008

Cited by 392 publications

(309 citation statements)

References 11 publications

Supporting

Mentioning

305

Contrasting

Unclassified

Order By: Relevance

“…In a national study in Norway, the rate was 42% and differed greatly across regions (16), and there was also a substantial between-ward variance in the use of seclusion, restraint and involuntary medication (17). European and US studies also find geographical variations with regard to the numbers of admissions and acute beds per 1000 inhabitants, staff/patient ratio and assessment and treatment strategies (5,6,16,(18)(19)(20). These variables may also differ across public and private inpatient facilities (21).…”

Section: Acute Psychiatric Admissionsmentioning

confidence: 99%

“…Suicidal risk at admission was assessed by rating patients on a scale from 1 to 6, where 1 = 'no risk' and 6 = 'recent severe self-harm with obvious intention to die' (17). Symptom severity and social and occupational functioning were measured by clinicians using the split version of the Global Assessment of Functioning (GAF) scale (18,19). Psychotic symptoms at the time of admission were assessed by the physician on call using the positive subscale of the Positive and Negative Syndrome Scale (PANSS) (20).…”

Section: Laboratory Measuresmentioning

confidence: 99%

See 1 more Smart Citation

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

Mordal

Bramness

Holm

et al. 2008

General Hospital Psychiatry

View full text Add to dashboard Cite

Section: Acute Psychiatric Admissionsmentioning

confidence: 99%

Section: Laboratory Measuresmentioning

confidence: 99%

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

Mordal

Bramness

Holm

et al. 2008

General Hospital Psychiatry

View full text Add to dashboard Cite

“…35 Psychosocial functioning was assessed using the split version of the Global Assessment of Function (GAF-S and GAF-F) scale. 36 Data on current antipsychotic medication was collected from interviews at time of MRI, by reviewing case notes or at time of the clinical interview. Defined Daily Doses (DDD) 37 were calculated.…”

Section: Clinical Assessmentsmentioning

confidence: 99%

Auditory Cortex Characteristics in Schizophrenia: Associations With Auditory Hallucinations

Mørch-Johnsen

Nesvåg

Jørgensen

et al. 2016

Schizophrenia Bulletin

View full text Add to dashboard Cite

There were no significant differences between AH+ and AH− patients in cortical thickness in the PT or STG, or in auditory cortex surface area in any of the regions investigated. Group differences in cortical thickness in the left HG was not affected by duration of illness or current antipsychotic medication. Conclusions: AH in schizophrenia patients were related to thinner cortex, but not smaller surface area of the left HG, a region which includes the primary auditory cortex. The results support that structural abnormalities of the auditory cortex underlie AH in schizophrenia.

show abstract

“…The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 27 was used for diagnostic purposes, and global symptomatology and functioning was measured by use of the Global Assessment of Functioning Scale (GAF; split version). 28 Interrater reliability was good, with an overall kappa score of 0.77 (95% confidence interval [CI] 0.60-0.94) for diagnoses and an intraclass correlation coefficient (type 1.1) of 0.86 for both symptom and function GAF scores.…”

Section: Assessmentsmentioning

confidence: 99%

Osteoprotegerin levels in patients with severe mental disorders

Hope

Melle²,

Aukrust³

et al. 2010

jpn

View full text Add to dashboard Cite

Background: Severe mental disorders are associated with elevated levels of inflammatory markers. In the present study, we investigated whether osteoprotegerin (OPG), a member of the tumour necrosis factor receptor family involved in calcification and inflammation, is elevated in patients with severe mental disorders. Methods: We measured the plasma levels of OPG in patients with severe mental disorders (n = 312; 125 with bipolar disorder and 187 with schizophrenia) and healthy volunteers (n = 239). Results: The mean plasma levels of OPG were significantly higher in patients than in controls (t 531 = 2.6, p = 0.01), with the same pattern in bipolar disorder and schizophrenia. The increase was significant after adjustment for possible confounding variables, including age, sex, ethnic background, alcohol consumption, liver and kidney function, diabetes, cardiovascular disease, autoimmune diseases and levels of cholesterol, glucose and C-reactive protein. Limitations: Owing to the cross-sectional design, it is difficult to determine causality. Conclusion: Our results indicate that elevated OPG levels are associated with severe mental disorders and suggest that mechanisms related to calcification and inflammation may play a role in disease development.

show abstract

Generalizability studies of the Global Assessment of Functioning–Split version

Cited by 392 publications

References 11 publications

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

Auditory Cortex Characteristics in Schizophrenia: Associations With Auditory Hallucinations

Osteoprotegerin levels in patients with severe mental disorders

Contact Info

Product

Resources

About